Who we are

Seagen is a global biotechnology company dedicated to revolutionizing cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives.

Our Mission

Our science

As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering safe and effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumours and blood-related cancers.

Learn More

Contact us / Site publisher

Seagen Denmark ApS

Agern Allé 24
2970 Hørsholm
Denmark

Telephone: +41 58 257 23 01
Email: OfficeDK@seagen.com

Registration number: 40738576
CRV number: 40738576

For medical information contact
(+46) 108 885 437
medinfoEU@seagen.com